We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.

1. you are allergic to medicines that contain clindamycin including those clindamycins taken by mouth or by injection (e.g. Dalacin) or lincomycin (e.g. Lincocin).

2. you are allergic to any other ingredients in this formulation.

3. you have a history of inflammatory diseases of the intestines or the large bowel (colitis, including ulcerative colitis, colitis caused by antibiotics, pseudomembranous colitis, or enteritis).

4. you are breastfeeding or plan to breastfeed.

5. the expiry date printed on the pack is passed.

1. you have a history of stomach or intestinal diseases.

2. you have any medical problems especially affecting the liver or kidney.

3. you are pregnant or plan on becoming pregnant during treatment.

4. you have very sensitive skin.

5. you have any skin disorders.

6. you are taking any medicines, especially

1. Do not swallow this medicine. Do not take this medicine by mouth. If you or someone else accidentally swallow some solution, contact a doctor or go to the casualty department at your nearest hospital immediately.

2. Do not use on open wounds.

3. Do not apply to the eyes, around eyelid areas, mouth, lips, mucosa or angles of the nose.

4. If the medicine does get in the eyes, wash them out immediately but carefully with large amounts of cool, clean water. If the eyes still burn or become painful, contact your doctor immediately.

5. Do not apply more often than or longer time than what your doctor told you because it may cause your skin to become too dry.

Can spirituality lead to better health outcomes? In this interview, we speak to Dr. Tracy Balboni from Harvard Medical School to find out more!

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

Dr. Philippe Saint Cricq Riviere

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information: verify here.

News-Medical.net - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022